Amounts which may be re-classified to the income statement: Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract] Derivatives Derivatives [member] Disclosure of contingent liabilities [line items] Disclosure of contingent liabilities [line items] DARZALEX and Kesimpta DARZALEX And Kesimpta [Member] This member stands for DARZALEX. Schedule of finance income and expenses Disclosure Of Finance Income Expenses [Table Text Block] na Investment in tangible assets Purchase of property, plant and equipment, classified as investing activities Share-based compensation expense Adjustments for share-based payments Other payables Other payables Translation reserves Reserve of exchange differences on translation [member] Hedged items [axis] Hedged items [axis] Classes of intangible assets and goodwill [axis] Classes of intangible assets and goodwill [axis] Interest Rate Swap Contract - 3.4885% Fixed Rate Termination Date June 2028 Interest Rate Swap Contract - 3.4885% Fixed Rate Termination Date June 2028 [Member] Interest Rate Swap Contract - 3.4885% Fixed Rate Termination Date June 2028 Other finance income Other finance income Levels of fair value hierarchy [domain] Levels of fair value hierarchy [domain] Total costs and operating expenses Operating expense Withholding taxes on behalf of employees on net settled RSUs Decrease (increase) through tax on share-based payment transactions, equity Change in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Increase (Decrease) in Operating Capital Royalties by Product [Axis] Royalties by Product [Axis] Information by royalties by product. Warrants Warrants [member] Schedule of level 3 reconciliation of assets Disclosure Of Fair Value Measurement Of Assets, Level 3 Reconciliation [Table Text Block] Tabular disclosure of level 3 reconciliation of assets measured at fair value. Cost of Product Cost of Product [Member] Cost of Product Schedule of intangible assets and goodwill Disclosure of reconciliation of changes in intangible assets and goodwill [text block] Number of new patents Number of New Patents On Which the Case Filed Number of New Patents On Which the Case Filed Accrued R&D Accrued R&D Accrued R&D Disclosure of disaggregation of revenue from contracts with customers [table] Disclosure of disaggregation of revenue from contracts with customers [table] Disclosure of detailed information about financial instruments [abstract] Disclosure of detailed information about financial instruments [abstract] Cash and cash equivalents include: Cash and cash equivalents [abstract] Schedule of fair value changes on Level 3 investments of assets Disclosure of fair value measurement of assets [text block] Total shareholders' equity Balance at beginning of period Balance at end of period Equity Disclosure of transactions between related parties [line items] Disclosure of transactions between related parties [line items] Disclosure of fair value measurement of assets [line items] Disclosure of fair value measurement of assets [line items] Amortization Amortisation expense Cash flows from operating activities before financial items Cash flows from (used in) operations Other comprehensive income: Other comprehensive income [abstract] Disclosure of detailed information about hedging instruments [line items] Disclosure of detailed information about hedging instruments [line items] Number of independent board members Number of Independent Board Members Number of independent board members. Property and equipment Property, plant and equipment Deferred tax benefit (expense) on cash flow hedges Income tax relating to cash flow hedges included in other comprehensive income Distributions Sales, fair value measurement, assets Marketable securities sold Proceeds From Sales Of Financial Assets At Fair Value Through Profit Or Loss, Classified As Investing Activities Proceeds From Sales Of Financial Assets At Fair Value Through Profit Or Loss, Classified As Investing Activities Net financial items Finance income (cost) Disclosure of transactions between related parties [abstract] Marketable securities bought Purchase Of Financial Assets At Fair Value Through Profit Or Loss Classified As Investing Activities Purchase Of Financial Assets At Fair Value Through Profit Or Loss Classified As Investing Activities Mijke Zachariasse, Martin Schultz and Michael Kavanagh Mijke Zachariasse, Martin Schultz And Michael Kavanagh [Member] Represents information pertaining to Mijke Zachariasse, Martin Schultz and Takahiro Hamatani. Other receivables and assets Other receivables Disclosure of detailed information about borrowings [table] Disclosure of detailed information about borrowings [table] Other investments Non-current investments other than investments accounted for using equity method RSUs vested (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement Increase (decrease) of trade receivables Increase (Decrease) of Trade Receivables Increase (Decrease) of Trade Receivables Interest elements of lease payments Interest Paid On Lease Liabilities, Classified As Operating Activities Interest Paid On Lease Liabilities, Classified As Operating Activities Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Elizabeth O’Farrell, Paolo Paoletti and Anders Gersel Pedersen Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Elizabeth O’Farrell, Paolo Paoletti and Anders Gersel Pedersen [Member] Represents information pertaining to Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Dr. Paolo Paoletti, and Dr. Anders Gersel Pedersen. Hedging instruments [axis] Hedging instruments [axis] Intangible assets and goodwill at beginning of period Intangible assets and goodwill at end of period Intangible assets and goodwill Interest Rate Swap Contract - 3.3960% Fixed Rate Termination Date June 2028 Interest Rate Swap Contract - 3.3960% Fixed Rate Termination Date June 2028 [Member] Interest Rate Swap Contract - 3.3960% Fixed Rate Termination Date June 2028 Consolidated Statements of Changes in Equity Statement of changes in equity [line items] Prepayments Prepayments Additions during the period Additions other than through business combinations, intangible assets other than goodwill Financial income Total financial income Finance income Precentage increase (decrease), collaboration agreements Increase (Decrease) of Collaboration Agreements, Percentage Increase (Decrease) of Collaboration Agreements, Percentage Level 1 Level 1 of fair value hierarchy [member] Borrowings, adjustment to interest rate basis Borrowings, adjustment to interest rate basis Re-election to the board of directors, term Re-Election to the Board of Directors, Term The term limit of board of directors who are re-elected. % change in share capital - warrants exercised Percentage Of Share Capital Attributed To Exercise Of Warrants Percentage of share capital attributed by exercise of warrants which increase the share capital. Increase (decrease) of collaboration agreements Increase (Decrease) of Collaboration Agreements Increase (Decrease) of Collaboration Agreements Transactions with owners: Transactions With Owners [Abstract] n/a Level 2 Level 2 of fair value hierarchy [member] Disclosure of non-adjusting events after reporting period [abstract] Litigation Case [Axis] Litigation Case [Axis] Derivatives [Abstract] Derivatives [Abstract] Derivatives [Abstract] Amortization Adjustments for amortisation expense Effect of exchange rate adjustment Increase (decrease) through net exchange differences, intangible assets and goodwill Share premium Share premium [member] Statement of financial position [abstract] Disclosure of contingent liabilities [abstract] Contract Liabilities Adjustments for increase (decrease) in contract liabilities Schedule of revenue by type, collaboration partner, and product under agreements. Disclosure of disaggregation of revenue from contracts with customers [text block] Cover [Abstract] Purchase of treasury shares Payments to acquire or redeem entity's shares Maximum Maximum [Member] Weighted average exercise price per warrant granted (in DKK per share) Weighted Average Exercise Price Of Warrants Granted Exercise price per share or per unit of warrants granted during the period. Summary of RSUs activity Disclosure of number and weighted average exercise prices of other equity instruments [text block] Acquisitions Purchases, fair value measurement, assets Schedule of receivables and other assets Disclosure Of Trade And Other Receivables [Table Text Block] Disclosure Of Trade And Other Receivables Total liabilities Liabilities Financial expenses: Financial Expenses [Abstract] na Total current liabilities Current liabilities Cash flow hedges Cash flow hedges [member] Share capital Issued capital Gain (loss) on hedge ineffectiveness recognised in profit or loss Gain (loss) on hedge ineffectiveness recognised in profit or loss Collaboration revenue Collaboration Revenue [Member] This member stands for collaboration revenue. Other Intangible Assets and Goodwill Disclosure of intangible assets and goodwill [text block] Trade and other receivables [abstract] Number of shares authorized for repurchase (in shares) Number Of Shares Authorized To Be Repurchased The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan. Transfers into Level 3 of fair value hierarchy, assets Transfers into Level 3 of fair value hierarchy, assets Collaborative Arrangement and Arrangement Other Than Collaborative [Domain] Collaborative Arrangement and Arrangement Other Than Collaborative [Domain] Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. Inventories Current inventories Deferred tax assets Deferred tax assets Share premium Share premium Cash flows from financing activities Cash flows from (used in) financing activities [abstract] Corporate tax payable Current tax liabilities, current Statement of profit or loss and other comprehensive income [abstract] Other Other Royalty Products [Member] Other Royalty Products Products and services [axis] Products and services [axis] Schedule of movement in borrowings Disclosure Of Reconciliation Of Borrowings Movement [Table Text Block] Disclosure Of Reconciliation Of Borrowings Movement Total comprehensive income Comprehensive income Statement of changes in equity [abstract] Retained earnings Retained earnings Corporate tax benefit / (expense) Tax expense (income) Subsequent Events to the Balance Sheet Date Disclosure of events after reporting period [text block] Basis of Presentation Disclosure of basis of preparation of financial statements [text block] Staff cost liabilities Provisions for employee benefits Fixed interest rate , derivatives (in percent) Derivatives, Fixed Interest Rate Derivatives, Fixed Interest Rate Total Trade and other receivables Cash flows from operating activities Cash flows from (used in) operating activities [abstract] Document Fiscal Period Focus Document Fiscal Period Focus Bank deposits Balances with banks Gain on other investments, net Gains On Other Investments, Net The gains on other investments. Loan modification and other adjustments Loan Modification And Other Adjustments Loan Modification And Other Adjustments Total assets Assets RSUs granted (in shares) Number of other equity instruments granted in share-based payment arrangement Selling, general and administrative expenses Selling, general and administrative expense Document Period End Date Document Period End Date Litigation Case [Domain] Litigation Case [Domain] Hedging instruments [domain] Hedging instruments [domain] Term B Loans (Secured) Term Loan B (Secured) [Member] Term Loan B (Secured) Types of risks [domain] Types of risks [domain] Receivables Adjustments for decrease (increase) in trade and other receivables Disclosure of detailed information about hedged items [table] Disclosure of detailed information about hedged items [table] Intangible assets and goodwill [abstract] Research and development expenses Research and development expense Gain on marketable securities Gains On Marketable Securities The gains on marketable securities. Interest paid Interest paid, classified as operating activities Goodwill Goodwill Revenue Revenue Warrants granted (in shares) Number Of Warrants Granted During Period The number of warrants granted during period. Foreign exchange rate gain Net foreign exchange gain Document Type Document Type Borrowings Disclosure of borrowings [text block] Share repurchase, percentage of share capital authorized Share Repurchase, Percentage of Share Capital Authorized Share Repurchase, Percentage of Share Capital Authorized TEPEZZA TEPEZZA [Member] This member stands for TEPEZZA. Collaborative Arrangement and Arrangement Other Than Collaborative [Axis] Collaborative Arrangement and Arrangement Other Than Collaborative [Axis] Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations. Share capital Issued capital [member] Classes of financial assets [axis] Classes of financial assets [axis] Geographical areas [axis] Geographical areas [axis] Amortization expense on borrowings Amortization Expense On Borrowings Amortization Expense On Borrowings Interest and other financial income Interest And Other Financial Income The interest and other financial income. Borrowings Current borrowings Financial income Adjustments for finance income Chugai Patent Infringement Complaint Chugai Patent Infringement Complaint [Member] Chugai Patent Infringement Complaint Share repurchase, percentage of purchase price deviation Share Repurchase, Percentage Of Purchase Price Deviation From Quoted Price Share Repurchase, Percentage Of Purchase Price Deviation From Quoted Price Profit or loss [abstract] Profit or loss [abstract] Reclassification adjustments on cash flow hedges, net of tax Fair Value (Gain)/Loss Reclassified to Profit or Loss Reclassification adjustments on cash flow hedges, net of tax Contract liabilities Current contract liabilities Lease liabilities Non-current lease liabilities Summary of warrants activity Disclosure Of Warrants Activity [Table Text Block] Tabular disclosure of warrants activity. Weighted average Black-Scholes fair value per warrant granted (in DKK per share) Weighted Average Exercise Price Of Fair Value Of Warrants Exercise price per share or per unit of fair value of warrants during the period. Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Accounts payable Trade payables Other intangible assets Intangible assets other than goodwill Borrowings by name [domain] Borrowings by name [domain] Types of share-based payment arrangements [domain] Types of share-based payment arrangements [domain] Disclosure of fair value measurement of assets [table] Disclosure of fair value measurement of assets [table] Range [axis] Range [axis] Acquired IPR&D Research and Development Expense In Process Research and Development [Member] In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process. Disclosure of reconciliation of changes in intangible assets and goodwill [abstract] Disclosure of reconciliation of changes in intangible assets and goodwill [abstract] Cash and cash equivalents Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash and cash equivalents Components of equity [axis] Components of equity [axis] RSUs Restricted share units [member] Other investments sold Proceeds from sales of investments other than investments accounted for using equity method Deferred tax liabilities Deferred tax liabilities Principal repayments on borrowings Principal repayments Repayments of current borrowings Technology Platform Technology-based intangible assets [member] Net profit before tax Net profit before tax Profit (loss) before tax Net product sales Net Product Sales [Member] Net Product Sales Other comprehensive income Other comprehensive income ASSETS Assets [abstract] Accrued interest Accrued Interest Expense, Borrowings Accrued Interest Expense, Borrowings Transfers out of Level 3 of fair value hierarchy, assets Transfers out of Level 3 of fair value hierarchy, assets Fair value changes Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, assets Other investments Other Investments1 [Member] Represents information pertaining to other investments. Schedule of borrowings Disclosure of detailed information about borrowings [text block] Total shareholders' equity and liabilities Equity and liabilities Change in cash and cash equivalents Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Types of share-based payment arrangements [axis] Types of share-based payment arrangements [axis] Business combinations [axis] Business combinations [axis] Percentage of share capital repurchased Percentage Of Share Capital Repurchased Percentage of share capital repurchased. Interest expense on borrowings Interest expense on borrowings Secured Notes Senior Secured Notes [Member] Senior Secured Notes Business combinations [domain] Business combinations [domain] Interest receivables Interest receivable Schedule of fair value changes on Level 3 investments of liabilities Disclosure of fair value measurement of liabilities [text block] Other payables Current other payables Other current payables Categories of related parties [domain] Categories of related parties [domain] Cash flow hedges [abstract] Cash flow hedges [abstract] Revenue [abstract] Revenue [abstract] Number of treasury shares cancelled Number Of Treasury Shares Cancelled Number Of Treasury Shares Cancelled Payment of withholding taxes on behalf of employees on net settled RSUs Payments Of Withholding Taxes On Behalf Of Employees On Net Settled RSUs The cash outflow for withholding taxes on behalf of employees on net settled restricted stock units (RSUs). Hedged items [domain] Hedged items [domain] Depreciation Adjustments for depreciation expense Weighted average exercise price on date of grant per warrant exercised (in DKK per share) Weighted Average Exercise Price Of Warrants Exercised Exercise price per share or per unit of warrants exercised during the period. Share-based reduction Share capital Reduction of issued capital Interest received Interest received, classified as operating activities Receivables & other non-current assets Receivables and other assets - non-current Trade and other non-current receivables Attribution of expenses by nature to their function [domain] Attribution of expenses by nature to their function [domain] Treasury shares outstanding (in shares) Number of Treasury Shares Outstanding The number of shares that has been held in treasury. Foreign exchange rate loss Net foreign exchange loss Products and services [domain] Products and services [domain] Schedule of derivative financial instruments Disclosure of detailed information about hedging instruments [text block] Interest rate risk Interest rate risk [member] Borrowings by name [axis] Borrowings by name [axis] Current financial assets Current financial assets Changes in fair value measurement, assets [abstract] Changes in fair value measurement, assets [abstract] Other Payables Disclosure of trade and other payables [text block] Interest Rate Swap Contract - 3.3625% Fixed Rate Termination Date June 2028 Interest Rate Swap Contract - 3.3625% Fixed Rate Termination Date June 2028 [Member] Interest Rate Swap Contract - 3.3625% Fixed Rate Termination Date June 2028 Roche Roche [Member] This member stands for collaboration arrangement with Roche. Disclosure of detailed information about intangible assets [table] Disclosure of detailed information about intangible assets [table] Other reserves Other reserves Disclosure of detailed information about hedging instruments [table] Disclosure of detailed information about hedging instruments [table] BioNTech BioNTech [Member] This member stands for collaboration arrangements with BioNTech. United States and Japan United States and Japan [Member] United States and Japan Borrowings beginning balance Borrowings end balance Borrowings Other Other Collaboration Partners [Member] Other Collaboration Partners Cash flows from investing activities Cash flows from (used in) investing activities [abstract] Loss on marketable securities Losses On Marketable Securities The losses on marketable securities. Short-term marketable securities Short-term investments, classified as cash equivalents Related Parties Disclosure of related party [text block] Classes of financial assets [domain] Classes of financial assets [domain] Basis of Presentation [Abstract] No definition available. Interest rate swaps Marketable Securities [Member] This member stands for marketable securities . Impairment losses for the period Impairment loss recognised in profit or loss, intangible assets and goodwill Board of directors, term Election to the Board of Directors, Term The term limit of board of directors. Interest Rate Swap Contract - 3.3355% Fixed Rate Termination Date June 2028 Interest Rate Swap Contract - 3.3355% Fixed Rate Termination Date June 2028 [Member] Interest Rate Swap Contract - 3.3355% Fixed Rate Termination Date June 2028 Classes of intangible assets and goodwill [domain] Classes of intangible assets and goodwill [domain] Net cash (used in) investing activities Cash flows from (used in) investing activities TEPKINLY TEPKINLY [Member] TEPKINLY Interest rate swap Interest rate swap contract [member] Kesimpta Kesimpta [Member] This member stands for Kesimpta. Derivative Financial Instruments Disclosure of derivative financial instruments [text block] Level 3 Level 3 of fair value hierarchy [member] Share-based compensation expenses Increase (decrease) through share-based payment transactions, equity Disclosure of detailed information about intangible assets [line items] Disclosure of detailed information about intangible assets [line items] Net cash (used in) financing activities Cash flows from (used in) financing activities Non-current financial assets Non-current financial assets Number of business units Number Of Business Units Number Of Business Units Other payables Non-current other payables Other non-current payables Amortization for the period Amortisation, intangible assets other than goodwill Total non-current assets Non-current assets Exchange differences on translation of foreign operations Other comprehensive income, net of tax, exchange differences on translation of foreign operations Number of non independent board members Number of Non Independent Board Members Number of non independent board members. Total current assets Current assets Accumulated amortisation and impairment Accumulated depreciation, amortisation and impairment [member] J&J J&J [Member] J&J Disclosure of disaggregation of revenue from contracts with customers [line items] Disclosure of disaggregation of revenue from contracts with customers [line items] Disclosure of disaggregation of revenue from contracts with customers [line items] Increase (decrease) in other payables Increase (Decrease) in Other Payables Increase (Decrease) in Other Payables Warrants exercised Proceeds from exercise of warrants Statement of changes in equity [table] Statement of changes in equity [table] Key management personnel of entity or parent Key management personnel of entity or parent [member] Receivables and Other Assets Disclosure of trade and other receivables [text block] Reimbursement revenue Reimbursement Revenue [Member] This member stands for reimbursement income. Goodwill Goodwill [member] Types of risks [axis] Types of risks [axis] Liabilities related to collaboration agreements Collaboration Agreements, Laibilities Collaboration Agreements, Laibilities Exchange rate adjustments Effect of exchange rate changes on cash and cash equivalents Current Current borrowings and current portion of non-current borrowings Cost of product sales Cost of sales Net cash provided by operating activities Cash flows from (used in) operating activities Impairment charges Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss Current Fiscal Year End Date Current Fiscal Year End Date Trade and other payables [abstract] Debt Issuance costs paid Payments for debt issue costs Weighted average fair value per RSU granted (in DKK per share) Weighted Average Fair Value Of Other Equity Instruments Granted In Share-based Payment Arrangement The weighted average fair value of other equity instruments (i.e. other than share options) granted in a share-based payment arrangement. Disclosure of terms and conditions of share-based payment arrangement [line items] Disclosure of terms and conditions of share-based payment arrangement [line items] Types of revenues [axis] Types Of Revenues [Axis] The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table. Types of hedges [domain] Types of hedges [domain] DARZALEX DARZALEX [Member] DARZALEX Share-Based Payments Disclosure of share-based payment arrangements [text block] Disclosure of transactions between related parties [table] Disclosure of transactions between related parties [table] Contract liabilities Non-current contract liabilities Geographical areas [domain] Geographical areas [domain] Other investments bought Purchase of investments other than investments accounted for using equity method Types of hedges [axis] Types of hedges [axis] Revenue Disclosure of revenue [text block] Document Fiscal Year Focus Document Fiscal Year Focus Receivables & other current assets Receivables and other assets - current Trade and other current receivables Corporate tax receivable Current tax assets, current Categories of related parties [axis] Categories of related parties [axis] Attribution of expenses by nature to their function [axis] Attribution of expenses by nature to their function [axis] Adjustments for non-cash transactions Adjustments to reconcile profit (loss) [abstract] Disclosure of detailed information about borrowings [line items] Disclosure of detailed information about borrowings [line items] Schedule of other payables Disclosure of Other Payables [Table Text Block] Disclosure of Other Payables Receivables and Other Current Assets [Table] Receivables and Other Current Assets [Table] Receivables and Other Current Assets [Table] Par value per share Par value per share Net profit Net profit Profit (loss) Carrying Value Fair value at beginning of period Fair value at end of period Financial assets Corporate taxes paid Income taxes paid, classified as operating activities Schedule of cash flow hedges Disclosure of information about amounts that affected statement of comprehensive income as result of hedge accounting [text block] Amendment Flag Amendment Flag Financial Instruments Disclosure of detailed information about financial instruments [text block] Components of equity Components of equity [domain] Levels of fair value hierarchy [axis] Levels of fair value hierarchy [axis] Total non-current liabilities Non-current liabilities ProfoundBio ProfoundBio [Member] This member stands for ProfoundBio. Financial expenses Total financial expenses Finance costs Number of employee elected board members Number of Employee Elected Board Members Number of employee elected board members. Number of patents Number Of Patents On Which The Case Filed Represents the number of patents on which the case is filed. Financial Income and Expenses [Abstract] NA Disclosure of credit risk exposure [table] Disclosure of credit risk exposure [table] Contingencies Disclosure of contingent liabilities [text block] Warrants exercised (in shares) Number Of Warrants Exercised During Period The number of warrants exercised during period. Other liabilities Other liabilities Number of shares acquired (in shares) Number Of Treasury Shares Acquired Number Of Treasury Shares Acquired Disclosure of detailed information about hedged items [line items] Disclosure of detailed information about hedged items [line items] Amortization of deferred financing fees Amortization of Deferred Financing Fees Amortization of Deferred Financing Fees Range [domain] Range [domain] Retained earnings Retained earnings [member] Types Of Revenues [Domain] Types Of Revenues [Domain] Types Of Revenues [Domain] Borrowings [abstract] Borrowings [abstract] Financial Income and Expenses Disclosure of finance income (cost) [text block] Deferred gains/(losses) on cash flow hedges, net of tax Fair Value (Gain)/Loss Deferred to OCI Gains (losses) on cash flow hedges, net of tax Disclosure of contingent liabilities [table] Disclosure of contingent liabilities [table] Entity Central Index Key Entity Central Index Key Carrying Value Opening Balance January 1, 2026 Closing Balance June 30, 2026 Derivative financial liabilities Disclosure of credit risk exposure [line items] Disclosure of credit risk exposure [line items] Excluding net product sales Excluding Net Product Sales [Member] Excluding Net Product Sales Trade receivables related to product sales Current trade receivables Pfizer Pfizer [Member] This member stands for Pfizer. Milestone revenue Milestone Revenue [Member] This member stands for revenue from milestone payments. Interest rate swaps Interest Rate Swaps Receivables Interest Rate Swaps Receivables Acquisition and integration related charges Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination Share-based compensation expenses Expense from share-based payment transactions Exercise of warrants Increase (decrease) through exercise of warrants, equity Gross carrying value Gross carrying amount [member] SHAREHOLDERS’ EQUITY AND LIABILITIES Equity and liabilities [abstract] Other payables Adjustments for increase (decrease) in other liabilities Financial expenses Adjustments for finance costs Gross deferred gains/(losses) on cash flow hedges Gains (losses) on cash flow hedges, before tax Accrued interest on borrowings Accrued Interest, Borrowings Accrued Interest, Borrowings Receivables and Other Current Assets [Line Items] Receivables and Other Current Assets [Line Items] Receivables and Other Current Assets [Line Items] Interest and other financial expenses Interest And Other Financial Expenses The interest and other financial expenses. Carrying amount Carrying amount [member] Notional amount Notional amount Royalties Royalties [Member] This member stands for revenue form royalties. Lease liabilities Current lease liabilities Operating profit Profit (loss) from operating activities Licenses and Patents Licenses and Patents [Member] This member stands for a class of intangible assets representing licenses and patents. Term A Loans (Secured) Term Loan A (Secured) [Member] Term Loan A (Secured) Borrowings Non-Current Non-current portion of non-current borrowings Inventories Adjustments for decrease (increase) in inventories Disclosure of terms and conditions of share-based payment arrangement [abstract] Diluted net profit per share (in dollars per share) Diluted earnings (loss) per share Principal elements of lease payments Payments of lease liabilities, classified as financing activities Right-of-use assets Right-of-use assets Disclosure of terms and conditions of share-based payment arrangement [table] Disclosure of terms and conditions of share-based payment arrangement [table] Purchase of treasury shares Acquisition of treasury shares Purchase of treasury shares Receivables related to collaboration agreements Collaboration Agreements, Receivables Collaboration Agreements, Receivables Unsecured Notes Senior Unsecured Notes [Member] Senior Unsecured Notes Royalties by Product [Domain] Royalties by Product [Domain] Information by royalties by product. Entity Registrant Name Entity Registrant Name Basic net profit per share (in dollars per share) Basic earnings (loss) per share Financial income: Financial Income [Abstract] na Investment in intangible assets Purchase of intangible assets, classified as investing activities Statement of cash flows [abstract] Novartis Novartis [Member] This member stands for collaborative arrangement with Novartis. Number of additional lawsuits Number Of Additional Lawsuits Number Of Additional Lawsuits